key Masimo additions include Next Generation SedLine ® Brain Function Monitoring, O3 ® Regional Oximetry, and ISA™ Capnography with NomoLine ® sampling lines. Masimo’s family of continuous ...

Masimo is positioned at the forefront of noninvasive monitoring technologies, notably with its SET and rainbow SET Pulse CO-Oximetry systems. These innovations enhance patient care by providing ...

Looking at Masimo’s peers in the patient monitoring segment, some have already reported their Q4 results, giving us a hint as to what we can expect. Insulet delivered year-on-year revenue growth ...

Masimo (NASDAQ: MASI) today announced that its management will participate in the 46th Annual Raymond James Institutional Investor Conference on Tuesday, March 4, 2025 at 11:35 a.m. Eastern time. A ...

Masimo (NASDAQ:MASI), a provider of noninvasive patient monitoring technology, released its fourth-quarter earnings for 2024, on Feb. 25, 2025. The results presented a mixed picture: strong ...